Categories
Pharmaceutical

MRI-guided Radiation Therapy Systems Market is projected to record a CAGR of approximately 20% through 2028

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.  This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.

The study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market. It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree. In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=2572

“Leading cancer research institutes are exploring the potential for MRI in radiation therapy in order to enhance the efficiency and precision of existing cancer treatments. However, integrating MRI technology, which uses magnetic field to produce images, with an all-metal linear accelerator in radiation therapy devices requires exceptional technological expertise and a strong international consortium. Currently, Elekta and Viewray are the only two companies that have a strong foothold in the MRI-guided radiation therapy systems market, and it may be a while until new entrants make foray into the market,” says Fact.MR.

global mri guided radio therapy systems market snapshot

Hospitals Remain the Target Customers for Market Players

The study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019. Opportunities abound for of MRI-guided radiation therapy system developers,, with ongoing clinical development of high-tech procedures exploiting Linac MR-RT (Linear accelerators integrated with magnetic resonance radiotherapy).

The study also finds that radiotherapy centers are adopting technologically-advanced MRI-compatible radiation models, to explore numerous possibilities to make radiotherapy treatment more effective. Market players are focusing on building a successful consortium with the help of physicians, clinicians, as well as Original Equipment Manufacturers (OEMs), to tap opportunities in the radiation therapy centers.

The study opines that the increasing healthcare expenditure in the United States (U.S.) will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America. In 2017, the per capita health expenditure was over US$10,000 in the U.S., recording an increase of nearly 4% over 2016, according to studies. In addition, an alarming rise in the prevalence of cancer in the U.S. will reflect in a significant demand for MRI-guided radiation therapy systems in North America.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=2572

According to the study, North America accounted for 45% sales of MRI-guided radiation therapy systems in 2018. Healthcare organizations in the region are investing heavily in tech-driven radiation treatments for cancer. While demand remains robust in developed markets, developing economies are also emerging as attractive markets for MRI-guided radiation therapy systems. Increasing government investments in healthcare infrastructure in the region, are expected to create new opportunities for the players in the MRI-guided radiation therapy systems market.

The study offers comprehensive outlook of the MRI-guided radiation therapy systems market for the period, 2018 to 2028. The MRI-guided radiation therapy systems market is projected to record a CAGR of approximately 20% through 2028.

Competitive Landscape

The only two MRI-guided radiation therapy systems manufacturers are Elekta AB, Viewray technologies, Inc. The market is still in its early days and thus there are not many market players. Their main focus is on developing MRI compatible modern radiation therapy system with no interference between two components. Development of such innovative products requires huge capital investment and extensive research. These two companies heavily rely on patenting and product licensing for revenue generation.

Get More insights- https://www.biospace.com/article/rising-demand-for-innovative-cancer-treatment-options-boosts-mri-guided-radiation-therapy-systems-demand-fact-mr/

Elekta AB is working towards building FDA approved products and capture maximum market shares in North America. Viweray technologies Inc made strategic collaboration with Minogue Medical Inc. and Device Technologies Australia Pvt Ltd to expand their market in Canada, Australia and New Zealand.

More Insights on the MRI-Guided Radiation Therapy Systems Market

In its latest report, Fact.MR offers unbiased analysis of MRI-guided radiation therapy systems market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (Linac MR-RT system, software), MR dimension (0.5 Tesla MR Scanner, 1.5 Tesla MR Scanner) and end user (hospital, Radiotherapy centers, Cancer research institutes) across six regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Explore Fact.MR’s Coverage on the Biospace Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/2572/mri-guided-radiation-therapy-system-market
Press Release: https://www.factmr.com/media-release/1004/global-mri-guided-radiation-therapy-system-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Antibiotic Residue Test Kits Market worth US$ 295 Million by 2026 – Exclusive Report by Fact.MR

Key role of simple diagnostic tests in detecting the presence of antibiotic residues in foods derived from animals will continue to propel the demand for antibiotic residue test kits. These tests ensure the food is safe for human consumption. Findings from these tests are of great value in increasing the nutritional index of animal-based foods. Moreover, stringent food safety measures continue to necessitate the need for adopting antibiotic residue test kits in the food & beverage industry.

Fact.MR’s recent report estimates the expansion of the global demand for antibiotic residue test kits for the period, 2021-2026. During this forecast period, the global antibiotic residue test kits market is expected to witness growth at 6.2% CAGR in terms of value. By the end of 2026, around US$ 295 Mn worth of antibiotic residue test kits are expected to be sold globally.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=496

global antibiotic residue test kits market

4 Key Highlights from the Report

1- According to the report, the adoption of beta-lactams tests will be the highest across the global antibiotic residue test kits market. The report observes that throughout the forecast period, sales of beta-lactams tests will account for approximately one-third share of global market revenues. By the end of 2026, nearly US$ 95 Mn worth of beta-lactams test kits will be sold globally. The demand for tetracycline tests will also gain traction in the upcoming years, bringing in around US$ 50 Mn in global revenues by the end of 2026. Meanwhile, sulfonamides tests will register fastest revenue growth at a CAGR of 7.1% over the forecast period.

2- Food and beverage industry will represent the largest end-user of antibiotic residue test kits. More than 65% of the global antibiotic residue test kits market value will be accounted by the end-use of these kits in ensuring the safety of food items and beverages, particularly for dairy products. The report also observes a rampant end-use of antibiotic residue test kits in veterinary purposes.

3- In 2017, North America registered highest sales of antibiotic residue test kits. The consumer marketplaces in the US and Canada will continue to promote the use of antibiotic residue test kits in food safety measures. By the end of 2026, North America will be dubbed as the largest market for antibiotic residue test kits, surpassing an estimated valuation of US$ 100 Mn.

4- Europe and the Asia-Pacific excluding Japan (APEJ) regions are also expected to be at the forefront of global antibiotic residue test kits market expansion. These two region will register fast revenue growth in their antibiotic residue test kits markets, particularly due to high presence of dairy product manufacturers.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=496

The report has profiled key companies developing antibiotic residue test kits across the globe. Companies namely, are observed as Thermo Fisher Scientific, Charm Sciences, DSM, Labtek Services Ltd., Perkin Elmer (Bio Scientific Corp.), IDEXX Labs, Neogen Food Safety, R-Biopharm AG, Sciex, and Eurofins are observed as key players in the global antibiotic residue test kits market. Majority of these players will be incorporating the advancements in the diagnostics of antibiotic residues. Extending the application of antibiotic residue test kits beyond measuring the safety of animal-based foods will also be prioritized by these companies in the near future.

Food & Beverage Industry End-use to Translate High Revenue Growth

In 2018 and beyond, antibiotic residue test kits will be predominantly used in the food and beverage industry.

A range of antibiotic residue test kits are being used for ensuring safety of milk and other dairy products.

Their use in inhibiting the growth of microorganisms through anti-infection principles will further extend their end-use in the global production of food items and beverages.

By the end of 2026, the end-use of antibiotic residue test kits in global food & beverage industry will bring in revenues worth over US$ 196 Mn.

The report also reveals that the veterinary end-use of antibiotic residue test kits will register fastest revenue growth at an estimated 6.7% CAGR over the forecast period.

Get More Insights- https://www.biospace.com/article/antibiotic-residue-test-kits-market-gaining-traction-as-a-food-safety-measure-fact-mr/

More Insights on the Antibiotic Residue Test Kits Market

In its latest report, Fact.MR offers unbiased analysis of the global antibiotic residue test kits market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of test type (beta-lactams, macrolides, tetracycline, Amino-glycosides, Amphenicols, and Sulfonamides) and end user (food and beverages industry, veterinary, and independent laboratory) across six regions (North America, Latin America, Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Paper Based Diagnostic Test Kits Market: A recent study by Fact.MR on the paper based diagnostic test kits market offers a 10-year forecast analysis for the period 2017 to 2027. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Direct Fluorescent Antibody Test Kits: Fact. MR’s extensive coverage on the direct fluorescent antibody test kits market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Ready-to-use Laboratory Test Kits: The global ready-to-use laboratory test kits market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/496/antibiotic-residue-test-kits-market
Press Release: https://www.factmr.com/media-release/427/antibiotic-residue-test-kits-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

MRI Safe Implantable Defibrillator Devices Market: Booming Demand from Emerging Economies to Market Growth Globally

Fact.MR has recently published a report, titled [Global MRI Safe Implantable Defibrillator Devices Market 2020 by Key Countries, Companies, Type and Application]. The research report provides an in-depth explanation of the various factors that are likely to drive the market. It discusses the future of the market by studying the historical details. Analysts have studied the ever-changing market dynamics to evaluate their impact on the overall market. In addition, the report also discusses the segments present in the market. Primary and secondary research methodologies have been used to provide the readers with an accurate and precise understanding of the overall The MRI Safe Implantable Defibrillator Devices market. Analysts have also given readers an unbiased opinion about the direction companies will take during the forecast period.

The global demand for MRI safe implantable defibrillator devices witnessed a slight fall in the first quarter of 2020 due to the spread of Covid-19 pandemic. Major attention was shifted towards preventing the ongoing crisis leading to neglecting further developments in this market. However, as the cases are getting down in 2021, incessant efforts of the market players are helping themto recuperate their market position.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=566

MRI Safe Implantable Defibrillator Devices Market: Drivers & Restraints

Several product advancements, rising geriatric population, increase in cardiac diseases and number of eligible population are some of the factors supporting the market growth of MRI safe implantable defibrillator devices. Furthermore, rising evidence about safety of these systems and effective marketing campaigns by various manufacturers supports the market growth of MRI safe implantable defibrillator devices. However, high product pricing and stringent regulatory issues for product approval lowers its market growth over the forecast period. Reimbursement issues, lack of skilled professionals in several countries are also limiting the market progress.

MRI Safe Implantable Defibrillator Devices Market: Segmentation
Segmentation by Product Type:
Single Chamber Defibrillator
Dual Chamber Defibrillator

Segmentation by Modality:

  • MR Conditional Defibrillator
  • MR Safe Defibrillator

Segmentation by End User

  • Hospitals
  • Ambulatory Surgical Centers

MRI Safe Implantable Defibrillator Devices Market: Overview
There are very few companies involved in the manufacturing of devices with MRI compatibility. The products are launched in the market only few years back. Medtronic announced the CE Mark and European launch of first MRI safe implantable defibrillator devices to allow for full-body MRI Scans in April 2014. USFDA has also approved the first MRI compatible ICD manufactured by Medtronic recently in September 2015. Despite the launch of MRI safe implantable defibrillator devices, most of the population is still present with the non-MRI compatible devices.

Companies in this direction are investing on research and development activities for advancement in these device types to improve therapy outcomes and manufacturing of low cost MRI safe implantable defibrillator devices. Top 3 companies in this market represent most of the market share globally for these MRI safe implantable defibrillator devices due to their strong presence, product approvals, brand strength and lack of competitors.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=566

MRI Safe Implantable Defibrillator Devices Market Treatment Market: Key Players
Some of the players in the MRI Safe Implantable Defibrillator Devices market includes Medtronic, Boston Scientific Corporation, Abbott, Microport, Biotronik etc.

The MRI Safe Implantable Defibrillator Devices market report addresses the below-mentioned queries:

  • Why are vendors shifting away from traditional methods of manufacturing MRI Safe Implantable Defibrillator Devices?
  • How does the global MRI Safe Implantable Defibrillator Devices market looks like in the next five years?
  • Which end use industry is expected to surpass segment by the end of Forecasted period?
  • What innovative products are being introduced by the players in the global MRI Safe Implantable Defibrillator Devices market?
  • Which regions are showing the fastest market growth?

Crucial insights in the MRI Safe Implantable Defibrillator Devices market research:

  • Underlying macro- and microeconomic factors impacting the growth of the market.
  • Basic overview of the MRI Safe Implantable Defibrillator Devices, including market definition, classification, and applications.
  • Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend of MRI Safe Implantable Defibrillator Devices across various industries.
  • Important regions and countries offering lucrative opportunities to market stakeholders.

Read More Trending Reports of Fact.MR: https://www.biospace.com/article/demand-for-acute-surgical-mechanical-circulatory-support-system-propelled-by-growing-prevalence-of-hf-says-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain
Bone Growth Stimulator Market: A recent study by Fact.MR on the bone growth stimulator market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth.

Bone Marrow Processing System Market: Fact.MR gives a detailed assessment of bone marrow processing system market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Injectable Bone Graft Substitutes Market: Fact.MR delivers an in-depth analysis on global injectable bone graft substitutes market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global Lab Workflow Solutions Market Is Anticipated To Gather Pace In Lucrative Regions Such As North America And Asia Pacific

The global Lab Workflow Solutions market is projected to show healthy growth during the forecast period of 2021-2031, finds Fact.MR in this study. Increasing burden from regulatory authorities for lab automation will create lucrative growth opportunities for the market.

The demand of lab workflow solutions market is anticipated to gather pace in lucrative regions such as North America and Asia Pacific. Expected to secure a larger share of the market in the near future, the developed region could bank on high digital literacy, better infrastructure, and the availability of policies supporting the deployment of laboratory information systems. Increasing pressure to end cost curve could result in high adoption of lab workflow solutions in the region. High number of pharmaceutical companies operating and increasing lab operational cost could be other reasons for increased demand for lab workflow solutions in the region.

To get in-depth insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=436  

Dependency for Regulating Routine Lab Workflows Stimulating Sales of Lab Workflow Solutions
With greater dependency on sample testing in the in-vitro space in healthcare domain, it has become essential to regulate and streamline day-to-day sample processing in laboratories. With that as a primary focus of various laboratories, the essentiality of lab workflow solutions has never been so imperative than it is today. This is massively pushing the adoption of various lab workflow solutions such as software and analytics to restructure and rationalize the sample data collected in labs, which is driving the growth of lab workflow solutions market.

In the era of IT implementation, changing reimbursement landscape and healthcare integration, improvements in lab workflow solutions should not be confined to laboratory success alone but should extend to various departments thus leveraging improvement opportunities across healthcare organizations.

Lab Workflow Solutions Market- Restraints
Higher capital cost and unclear regulatory guidelines for medical application is likely to impede the growth of lab workflow solutions market. Higher cost of lab workflow solutions instrument is a major factor hampering its adoption across resource-poor countries. The overall cost of lab workflow solutions’ implementation would be beyond budget for some medium scale laboratories. Moreover, higher maintenance costs associated with DP installations and costlier training and development programs for end users are other factors likely to restrain the growth of lab workflow solutions market.

Lack of awareness regarding lab workflow solution systems and cloud-enabled technologies, especially in developing economies such as China and India, is restraining growth of the market. This is ultimately increasing the cost of on-premise platforms, which in turn increases total expenditure on lab workflow solutions technology. Such rising capital expenditure on hardware and storage is reducing the adoption of lab workflow solution, thereby hampering the market growth.

Empowering Diagnostics with Lab Workflow Solutions
With increasing complexity in diagnostic laboratories, the need for critical management to ensure balance between financial and operational priorities including managing personnel, budgets, customer satisfaction and quality assurance has become vital in diagnostic laboratories. With advanced lab workflow solutions, diagnostics can be taken to a next level using a holistic approach to facilitate speed, cost reductions and quality, consequently enabling efficient implementation, laboratory benchmarking and overall lab workflow.

Share Your Requirements & Get Customized Reports https://www.factmr.com/connectus/sample?flag=RC&rep_id=436  

Lab Workflow Solutions Market- Key Companies
Perkin Elmer, Inc., GE Healthcare, Definiens AG, Koninklijke Philips N.V, Sectra ABss, Ventana Medical Systems, Inc., 3D-Histech Ltd, Inspirata Co., Leica Biosystems, Quorum Technologies Inc., Hamamatsu Photonics, K.K., Yokogawa Electronic Corporation, Digipath Co., Olympus Corporation and ZEISS are some of the key companies which provide lab workflow solutions across the globe.

Lab Workflow Solutions Market- Drivers
Growing demand for laboratory services has increased the importance of lab workflow solutions over the past few years. The lab industry has witnessed a significant transitions in terms of sample processing. These in-vitro diagnostic technologies have increased the pace of lab services. However, limitation in terms of sample processing and availability of skilled work force in the lab space have reduced the efficacy of lab services. The lab workflow solution market is emerging as a novel solution to these problems. Presently, lab workflow solutions are reasonably dominant in the research and development sector. Going forward, they are likely to be established as a one of the key components in lab industry, owing to their promising attributes over conventional lab techniques.

The lab workflow solutions market is being shaped by the collaborative approach between pathology laboratories and research centers with cloud service providers. This is expected to increase awareness regarding lab workflow solution technology, and also provide new platforms to end users, thereby fuelling the growth of lab workflow solutions market.

Regional Segments Analyzed Include

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

Read More Trending Reports of Fact.MR:  https://www.biospace.com/article/cytomegalovirus-assay-demand-spurred-by-increasing-cytomegalovirus-infection-cases-says-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain –
Lab Automation Market– Fact.MR in its latest report has an in-depth analysis that examines the global sales of lab automation equipment and software in 20+ high-growth markets, as well as the influence of COVID-19 on the healthcare business in general and lab automation demand in particular.

Lab Workflow Solutions Market– Due to national mandated lockdown and social distance enacted in 2020, global demand for lab workflow solutions decreased slightly during the Covid-19 pandemic. In 2021, there will be a strong preference for lab workflow solutions due to the growing need for standardized procedures in clinical laboratories such as sample receipts, handlings, and preparation of lab samples, guidance for assay data collection, and the reduction of potential errors.

Ready-to-use Laboratory Test Kits Market– Healthcare providers are increasingly requesting ready-to-use laboratory test kits since they give innovative solutions as well as technical assistance. The ready-to-use laboratory test kits are accurate, simple to use, and enable for rapid diagnosis of a wide range of infectious disorders.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Interventional ENT devices are increasingly adopted due to the cosmetic advancements in the healthcare sector

The spread of Covid-19 pandemic declined the global sales of interventional ENT devices in 2020 leading to slowdown in its market progress. Due to economic slowdown, the government lifted up all the restrictions and allowed manufacturing companies to start back their operations.

The Ester Gum industry will see significant growth and a robust CAGR over the forecast period. According to the latest research report by Verified Market Research, the development of the Interventional ENT Devices Market is mainly supported by a sharp increase in demand for products and services in this industry. A detailed summary of Interventional ENT Devices Market valuation, sales estimate, and market stats is an important part of the report. Hence, the aim of the report is to help readers gain viable insights into the competitive spectrum of the Interventional ENT Devices Market. It also draws attention to the important business expansion strategies pursued by the major competitors in the market in order to strengthen their position in the world market.

For detailed insights on enhancing your product footprint, request for a sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=978

Competitive Landscape
The report presents the business mechanisms and growth-oriented approaches of leading companies operating in this Interventional ENT Devices Market. The report highlights the numerous strategic initiatives such as new deals and collaborations, mergers and acquisitions, joint ventures, product launches, and technology upgrades being implemented by leading market competitors to gain a foothold in the marketplace. Therefore, this section contains the company profiles of the major players, the accumulation of total sales, product sales, profit margins, product prices, sales and distribution channels, and industry analyzes.

Interventional ENT Devices Market: Key Players
The global market for interventional ENT devices market is highly fragmented. Examples of some of the key players operating in the global interventional ENT devices market are Medtronic PLC, Karl STORZ GmbH & Co., Olympus Corporation, Stryker Corporation, Acclarent Inc., Sonova Holdings AG, Hoya Corporation, William Demant Holdings A/S and Cochlear Limited.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Interventional ENT Devices Market: Segmentation
Tentatively, the global Interventional ENT devices market can be segmented on the basis of treatment, end user and geography.
Based on Product Type, the global Interventional ENT devices market is segmented as:

  • Radiofrequency headpiece
  • Powered surgical instrument
  • Ontological drill burs
  • ENT hand instruments
  • Sinus dilation devices
  • Nasal packing devices
  • Tympanostomy tubes

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=978

Based on end user, the global Interventional ENT devices market is segmented as:

  • Hospital
  • Specialty clinic
  • Ambulatory surgical center

Geographical Analysis of the Interventional ENT Devices Market:
The latest Business Intelligence report analyzes the Interventional ENT Devices Market in terms of market size and consumer base in major market regions. The Interventional ENT Devices Market can be divided into North America, Asia Pacific, Europe, Latin America, Middle East and Africa based on geography. This section of the report carefully assesses the presence of the Interventional ENT Devices Market in key regions. It determines the market share, the market size, the sales contribution, the distribution network and the distribution channels of each regional segment.

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Interventional ENT Devices market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Interventional ENT Devices market.

Geographic Segment Covered in the Report:

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Read More Trending and Similar Reports from Fact.MR: http://www.globenewswire.com/en/news-release/2019/04/05/1797696/0/en/Citicoline-Sales-Driven-by-Supplement-Demand-from-Geriatric-Population-and-eSports-Players-Fact-MR-Study.html

Explore Fact.MR’s Coverage on the Healthcare Domain :
Diagnostic Imaging Services Market: The global diagnostic imaging services market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

Portable Dialysis Machines Market: Fact. MR’s extensive coverage on portable dialysis machines market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent Product Type and end users, along with important information concerning key manufacturers operating within the industry.

Bioabsorbable Osteosynthesis Devices Market: Bioabsorbable Osteosynthesis Devices Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2026

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Bioabsorbable Osteosynthesis Devices Market Unidentified Segments – The Biggest Opportunity Of 2021

According to Fact.MR, Insights of Bioabsorbable Osteosynthesis Devices is a specialized and in-depth study of the industry with a special focus on the Key Trends of Bioabsorbable Osteosynthesis Devices is a Service. The report aims to provide an overview with detailed segmentation by type, application, end use and geography. The global is expected to witness high growth during the forecast period.

The Most Recent study on the Bioabsorbable Osteosynthesis Devices Market Research provides a profound comprehension of the various market dynamics like trends, drivers, the challenges, and opportunities. The report further elaborates on the micro and macro-economic elements that are predicted to shape the increase of the Bioabsorbable Osteosynthesis Devices market throughout the forecast period (2021-2031).

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=862

The introduced study elucidates the crucial indicators of Market growth which comes with a thorough analysis of this value chain, CAGR development, and Porter’s Five Forces Analysis. This data may enable readers to understand the quantitative growth parameters of this international industry that is Bioabsorbable Osteosynthesis Devices.

The global bioabsorbable osteosynthesis devices market is apprehended to see impressive growth in the near future due to new product launches, an encouraging sign can be observed in the market with changing consumer trends. The expansion in products manufactured with bioabsorbable material is driven by year on year rises in the susceptible complications observed in the use of metal implants. Top players are marking their presence in many developing economies due to the liberal policies regulated within the healthcare industry in such countries, increasing consumer inclination towards maintaining an aesthetic and approachable appearance.

Priority is given to eliminate the adverse effects such as migraine, growth disturbance, radio-opacity and more and provide a safe environment for the body. Bioabsorbable polymers are manufactured with a lot of judgment calls in order to provide a safe material to be in use. As the applications of bioabsorbable osteosynthesis devices in orthopaedic surgery have mainly been used to eliminate implant removal procedures. Choices of materials are there with companies investing on such research and but with majority of devices being manufactured using non-bioabsorbable material due to the traditional methods or major dependency on such principles which could hamper the growth of the market in the near future.

The global market for bioabsorbable osteosynthesis devices is segmented on the basis of product type, material type and end users:

By Product Type

  • Plate
  • Pin
  • Screw
  • Rod
  • Wire

By Material

  • PLLA
  • PLA
  • PGA
  • Others

By End Users

  • Hospital
  • ASCs
  • Clinic

To receive extensive list of important regions, ask for TOC here- https://www.factmr.com/connectus/sample?flag=T&rep_id=862

Bioabsorbable Osteosynthesis Devices Market: Key Players
Population density is expected to escalate in the Asia Pacific (exc. China) region allowing more market opportunity for bioabsorbable osteosynthesis devices to establish and produce goods within the region. Europe is expected to grow at a higher rate due to rise in population, changing lifestyle and rise in awareness among consumers and suppliers. China is expected to have a fragmented market with more number of regional players and low adoption of bioabsorbable material.

Economic growth is supporting the health care infrastructure in developing countries allowing more number of players to contribute with ease and efficiency. Examples of some of the key players in the global bioabsorbable osteosynthesis devices market are Arthrex, CONMED Corporation, Acumed, Ziacom Medical, ETGAR medical implant system, Jeil Medical Corporation, Medical Instinct Deutschland GmbH and more. Acquisition, mergers, strategic collaborations, and technology play vital roles in the growth of the bioabsorbable osteosynthesis devices market.

The report covers exhaustive analysis on:

  • Bioabsorbable Osteosynthesis Devices Market Segments
  • Bioabsorbable Osteosynthesis Devices Market Dynamics
  • Historical Actual Market Size, 2013- 2016
  • Bioabsorbable Osteosynthesis Devices Market Size & Forecast 2017 to 2025
  • Bioabsorbable Osteosynthesis Devices Market Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Bioabsorbable Osteosynthesis Devices Market Drivers And Restraints

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

Explore Fact.MR’s Coverage on the Biospace Domain
Cervical Dysplasia Diagnostics Market: A recent study by Fact.MR on the cervical dysplasia diagnostics market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market.

Cervical Dystonia Treatment Market: Fact. MR’s extensive coverage on cervical dystonia treatment market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Cervical Anterior Approach Device Package Market: The global cervical anterior approach device package market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Recent Technological Advancements to Propel Demand of the Nucleic Acid Extraction System Market, Says Fact.MR

Fact.MR, a global research firm, in its latest study on the nucleic acid extraction system market, projected the market to record a robust CAGR in 2021. The growth of the nucleic acid extraction system market is mainly due to the wide-range applications of nucleic acid testing in diagnostics, rapid advancements in technology, and increment in the R&D funding in healthcare and biotechnology. 

The growing penetration of automotive processes in R&D has increased the need for technologically advanced automatic nucleic acid extraction system. Automated nucleic acid extraction system makes a viable option over manual variants as it offers cleaner and more consistent extraction of nucleic acid in lesser time. With an ability to run several processes simultaneously with minimal error ratio, the adoption of nucleic acid extraction system is likely to grow. Such benefits are further likely to fuel gains in the nucleic acid extraction system market.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=432  

Technological Progressions Continues to Drive Nucleic Acid Extraction System 
Technological progressions in sample preparation technique for nucleic acid extraction, agreement amid topmost research institutes to increase research activities in relation to molecular biology, growing demand for novel extraction techniques and progressions in technology in analytical instruments are a few of the key drivers.

Fact.MR’s study reflects that rapid advancement in technology, such as polymerase chain reaction (the initial nucleic acid amplification method), that transformed the method of the clinical microbiologists in viewing and utilizing nucleic acid methods in clinical settings is steering the growth in the market.

Aero chambers Demand Set to Increase
Nucleic acid extraction system market are extensively utilized in hospitals & diagnostic centers, academic research institutes, contract research organizations (CROs), pharmaceutical & biotechnology companies, and others (such as forensic laboratories and food testing). The academic research institutes are widely utilizing nucleic acid extraction systems as it plays a vital role in the customized and predicative medication.

Whereas, hospitals & diagnostic centers are gradually catching up on the back of surging use of nucleic acid tests in molecular diagnostics.

How big is the US Nucleic Acid Extraction System Market?
The U.S. has reflected rapid progression in technologies and has rigorous standards for pharmaceuticals analysis. This is projected to propel growth of nucleic acid extraction system in the region. In the UK, key biotech firms are undergoing scale-up of operations and commercialization that is projected to boost demand for nucleic acid extraction systems. Japan, China, and India offer huge growth prospects for the market, owing to growing R&D expenditure and advancements in technology in these nations.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=432

Agreements & Partnership Models Remains Key Focus Areas: Fact.MR Survey
Nucleic acid extraction system market is fragmented, competitive and comprises of various key players. Fact.MR’s survey with thought leaders revealed that agreements and partnership models to fortify their businesses will remain a prominent strategy for market players in 2021 & beyond. The updated edition of the report provides comprehensive coverage of the projected to remain the key strategies of market players. Some of the players profiled in the report are Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Sigma Aldrich Corp., Tecan Group AG., Becton Dickinson and Company, Bio-Rad Laboratories Inc., QIAGEN, PerkinElmer, Inc., DiaSorin S.p.A, and F. Hoffmann-La Roche. The updated edition also offers a detailed analysis of the COVID-19 impact on this market.

Crucial insights in the Nucleic Acid Extraction System market research:

  • Underlying macro- and microeconomic factors impacting the growth of the market.
  • Basic overview of the Nucleic Acid Extraction System, including market definition, classification, and applications.
  • Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend of Nucleic Acid Extraction System across various industries.
  • Important regions and countries offering lucrative opportunities to market stakeholders.

Read More Trending Reports of Fact.MR : https://www.biospace.com/article/fact-mr-says-growth-of-keratoprosthesis-market-steered-by-increasing-incidences-of-corneal-blindness

Explore Fact.MR’s Healthcare Reports 
Carotid Stenting Systems Market: Delve into Fact.MR’s extensive study on the carotid stenting systems market, offering detailed assessment. The study analyzes crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Injection Pen Market: The global injection pen market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Leukocytapheresis Device Market: Fact.MR’s global leukocytapheresis device market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Melanoma Cancer Diagnostics Market is expected to register CAGR of 4.7% by the end of 2028

Growing emphasis on early detection and prevention is driving the melanoma cancer diagnostics market, with global revenue surpassing US$ 800 million in 2018, according to a new study conducted by Fact.MR. The growth of the market is steady in countries/regions with higher prevalence of melanoma. Spending on advanced and safe melanoma cancer diagnostics is growing in the US, as efforts to diagnose the disease at an early stage gain traction.

The American Academy of Dermatology estimates around 9,500 people in the US are diagnosed with skin cancer and more than 1 million people in the US are living with melanoma. With skin cancer as most common form of cancer in the US, an increasing number of people are receiving skin cancer diagnosis every year compared to other type of cancers.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=57

Extensive usage of tanning beds is also leading to the rise in melanoma cancer rates globally. Researchers have also found that UV light from sun and tanning beds not only causes melanoma but increases the risk of benign mole which can progress to melanoma. Europe also shows potential for expansion in melanoma cancer diagnostics owing to the treatment rates, government initiatives supporting diagnosis and treatment, and availability of premium drugs.

Increasing Incidences of Skin Cancer Driving Demand for Melanoma Cancer Diagnostics

According to the World Health Organization (WHO), around 132,000 melanoma skin cancers occur worldwide every year. It is also estimated that about 10% decrease in ozone levels is likely to result in 4,500 melanoma skin cancer cases.

There were nearly 300,000 new melanoma of skin cases in 2018, as per the American Institute of Cancer Research.

With the number of skin cancer cases going up in the past few years, focus on providing early detection and diagnosis is increasing.

Melanoma cancer is on a rise owing to the changing environmental conditions and increasing exposure to UV rays. This is driving the demand for rapid diagnostics for early detection of melanoma cancer.

melanoma cancer diagnostics market pricing analysis by test type 2017 &...

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=57

Fluorescent In Situ Hybridization (FISH) Emerging Highly Preferred Test Type

High sensitivity, specificity and speed at which assays can be performed is resulting in significant use of Fluorescent In Situ Hybridization (FISH) test in both research and diagnosis of skin cancer and solid tumors. Fact.MR expects FISH Test to witness steady growth, exceeding US$ 300 million in 2018.

FISH is offering identification of genetic changes that are too small to be visible under microscope. Moreover, FISH test is not required to be performed on the cells actively dividing making it faster than other types of test. With an emphasis on early detection of skin cancer, FISH is becoming a vital tool to detect cancer. FISH is also witnessing significant adoption in detecting melanoma cancer diagnosis compared to Comparative Genomic Hybridization (CGH) Tests, owing to the technical limitations in CGH.

With a significant rise in melanoma cancer, diagnosis is becoming challenging, particularly in case of thin, small, and early-stage melanoma. The biopsy of lesion is performed largely at pathology laboratories to detect melanoma owing to the need for accurate results in early-stage. Majority of the skin biopsy samples are tested at pathology laboratory owing to the availability of advanced tools, microscopes, and special stains to make correct diagnosis.

Get More Insights- https://www.biospace.com/article/melanoma-cancer-diagnostics-market-to-rely-on-fish-and-ai-for-future-expansion-fact-mr/

Regulatory standards have also been introduced to ensure materials and equipment used at labs are valid. This has resulted in the development of reliable methods and process to ensure accurate and timely report of the patient. Pathology laboratories are focusing on standard operating procedures with some alterations in molecular testing. The personalized medicine for cancer is also gaining traction, driving rapid development of molecular testing with need for information required to guide accurate treatment.

The Fact.MR report tracks the melanoma cancer diagnostics market for the period 2018-2028. According to the report, melanoma cancer diagnostics market is expected to register CAGR of 4.7% between 2018 and 2028.

Explore Fact.MR’s Coverage on the Healthcare Domain

Breast Cancer Diagnostics Market: A recent study by Fact.MR on the breast cancer diagnostics market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Ovarian Cancer Diagnostics Market: Fact.MR gives a detailed assessment of ovarian cancer diagnostics market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Prostate Cancer Diagnostics Market: Fact.MR delivers an in-depth analysis on global prostate cancer diagnostics market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/57/melanoma-cancer-diagnostics-market
Press Release: https://www.factmr.com/media-release/1063/global-melanoma-cancer-diagnostics-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

North America to Remain the Most Lucrative Market for Speech Generating Devices, Reveals Fact.MR

The global demand for speech generating devices market is expected to exhibit a staggering expansion at 12.2% CAGR over the forecast period 2017 to 2022, according to a report by Fact.MR. The report anticipates the market to account for revenues worth US$ 168.6 Mn in 2017, and the market is further estimated to reach nearly US$ 300 Mn by 2022-end.

Various developments in electronic technology have been witnessed over the past decade, rendering the speech generating devices portable and more user interactive. Speech generating devices exist in several variants on the basis of levels of cognitive abilities, physical abilities, symbol system, tongue switches, text, and eye tracking system.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=53

Growth of the global speech generating devices market is primarily attributed to increasing availability of user-friendly devices and advancements in technology. According to the National Institute of Deafness & Other Communication Disorders (NIDCD), it is estimated that approximately 7.5 Mn of the U.S. population is affected with some kind of speech related disorders.

Global leaders in speech generating devices market are focusing on enhancement of touch-screen devices for the provision of easy navigation to users. In addition, these manufacturers are providing speech generating devices with the ability to connect with variety of smart phone versions such as iPhone and Android.

On the back of speech generating devices’ portable nature, demand for these devices is gaining higher traction among patients with speech impairments. This is further expected to create huge opportunities for manufacturers of speech generating devices. However, factors such as low penetration of speech generating devices, coupled with their high cost are expected to inhibit growth of the market during the forecast period.

Share Your Requirements & Get Customized Reports –https://www.factmr.com/connectus/sample?flag=RC&rep_id=53

Projections for the Global Speech Generating Devices Market
  1. North America will continue to be the most lucrative region for growth of the speech generating devices market, followed by Europe. Revenue from sales of speech generating devices in North America is expected to reach US$ 126.7 Mn by 2022-end.
  2. Sales of speech generating devices in Asia-Pacific excluding Japan (APEJ) will continue to register the fastest expansion during the forecast period.
  3. Synthesized speech devices will remain preferred among products in the market, followed by picture communicators.
  4. Sales of text-to-speech devices are expected to register the highest CAGR in the market through 2022.
  5. On the basis of display, although static display for speech generating devices will remain sought-after in the market, sales of dynamic display will exhibit a comparatively faster expansion throughout the forecast period.
  6. Specialty clinics are expected to remain the largest distribution channel for sales of speech generating devices, expanding at the highest CAGR through 2022.
  7. Hospitals will continue to hold second position in the market based on distribution channel, to account for more than US$ 100 Mn by 2022-end.
  8. By technology, manual speech generating devices will witness largest adoption, followed by head tracking and eye tracking technology-based speech generating devices.
  9. Fact.MR’ report profiles key players in the global speech generating devices market, which include Tobii Dynavox, Prentke Romich Company, Inc., Lingraphica, Abilia Toby Churchill Limited, AMDi, Textspeak, Saltillo Corporation, Zyteq Pty Ltd., and Zygo USA.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=53

Prominent Drivers

  • Advancement in technology and rising availability of user-friendly devices to improve the demand
  • Increased adoption of portable devices among patients with speech related disorder is accelerating the sales of speech generating devices
  • Demand for enhanced touch-screen devices with multiple facilities to create growth opportunities for market players

Key Restraints

  • High cost and low penetration of speech generating devices to curb the growth of market
Static Display for Speech Generating Devices to Remain Sought-After in the Market

On the basis of display, even though speech generating devices with static display will remain sought-after, sales of speech-generating devices with dynamic display will continue to exhibit a comparatively higher CAGR through 2022.

Specialty clinics will remain dominant among distribution channels in the global speech-generating devices market, witnessing expansion at the highest CAGR during the forecast period.

Hospitals will remain the second most lucrative distribution channel for speech generating devices in the market, estimated to account for over US$ 100 Mn by 2022-end. Based on technology, the manual segment will witness the largest adoption in the market, followed by eye tracking and head tracking technology-based speech-generating devices.

Get More insights- https://www.biospace.com/article/smart-speech-generating-devices-sgds-sales-increasing-with-rising-cases-of-speech-related-disorders-fact-mr/

More Insights on the Speech Generating Devices Market

Fact.MR offers an unbiased analysis on global speech generating devices market. The report offers a detailed segmentation on Speech Generating Devices market on the basis of product (synthesized speech devices, text-to-speech devices, and picture communicators), display (static display and dynamic display), distribution channel (hospitals, specialty clinics, and e-commerce), and technology (manual devices, head tracking technology) across seven regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Phototherapy Devices Market: A recent study by Fact.MR on the phototherapy devices market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Radiotherapy Devices Market: A detailed assessment of radiotherapy devices market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Dermatology Devices Market: Fact.MR delivers a detailed analysis on global dermatology devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/53/speech-generating-devices-market
Press Release: https://www.factmr.com/media-release/39/global-speech-generating-devices-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Rise of New Demography for Anti-aging Serums ,Owing to the Care of the Texture of Skin

In recent times, the ‘salon at home’ culture has been gaining wide acceptance, which is projected to arise as a crucial end user in the anti-aging and anti-wrinkle products market. The advent of brand-owned salons in key localities is a significant parameter driving the sales of anti-aging and anti-wrinkle products. On the demand side, consumers, especially females, are increasingly conscious about their looks, which is encouraging them to try out various creams and serums to achieve flawless skin.

The proclivity of consumers for premium and branded products is growing, powered by an increase in their discretionary spending. However, as cases of the side effects of these products are coming to light, a shift has been witnessed in the consumption pattern towards products with organic and natural ingredients, which is also indicative of the shift in manufacturers’ production strategy.

For detailed insights on enhancing your product footprint, request a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4337

“High density of the generation X demography in China, which is the key target group, will retain the attractive quotient of the local anti-aging and anti-wrinkle products market. The presence of leading online channels will further drive profitability to the Chinese market during the forecast period”,opines a subject matter expert at Fact.MR.

Given the influence of the changing dynamics, an exclusive study published by Fact.MR foresees a moderate growth pace of the anti-aging and anti-wrinkle products market, at an estimated CAGR of 6% during the forecast period (2020-2027).

Key Takeaways of Anti-aging and Anti-wrinkle Products Market Study

  • The preference for creams among other beauty products – serums and gels – will remain high, owing to their easy availability and application. In addition, creams are an integral part of a daily beauty routine, and this is likely to offer sustainable supply opportunities to manufacturers.
  • Though the anti-aging and anti-wrinkle products market has been a female-driven landscape, increasing look-consciousness among males is projected to add a new dimension to the existing sales scenario of the landscape.
  • Critical moisturizing properties of hyaluronic acids are predicted to extend the frontiers of their application in anti-wrinkle gels, creams, and serums, during the forecast period.
  • Consumers’ proclivity for facial care treatment will remain relatively high as compared to body care treatment. The sales of anti-aging and anti-wrinkle products through facial care treatment are expected to account for ~74% of the total share by 2027.
  • Manufacturers are adopting effective marketing strategies through powerful keywords, such as immediate, quick-fix, and instant, which have been found to be successful in drawing increased consumer attention.
  • Brand-owned stores will remain robust distribution channels to disseminate information about new anti-aging and anti-wrinkle products; however, sales from online stores are projected to grow exponentially, as deals and discounts remain attractive features of this channel.

Have a Query? Speak to Research Analyst https://www.factmr.com/connectus/sample?flag=AE&rep_id=4337

Anti-aging and Anti-wrinkle Products Market – Assessment of Key Segments

Product
  • Serum
  • Creams
  • Gels
  • Others
Gender
  • Male
  • Female
Ingredient
  • Retinoid
  • Hyaluronic Acids
  • Alpha-Hydroxy Acids
  • Others
Treatment
  • Body Care Treatment
  • Facial Care Treatment
Distribution Channel
  • Pharmacies
  • Stores
  • Online Stores
Region
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Full Access of this Report Is Available At
https://www.factmr.com/checkout/4337

Shift from Artificial Ingredients to Organic Products to Remain Profitable

The anti-aging and anti-wrinkle products market is fragmented in nature, with a handful of players leading at the international front, and facing intense competition from domestic players.

Players in the anti-aging and anti-wrinkle products market, however, are facing headwinds from stringent regulatory norms, which is leading to frequent product recalls. Given this influence, manufacturers in the anti-aging and anti-wrinkle products market are increasing investments in research & development activities to launch new products. For instance, a key player – Clinique – announced the launch of a repair serum, which is suitable for all skin types, to control puffiness, and, in turn, slow the aging process.

Growing consciousness regarding the side effects of chemical-based products is leading to a shift in the raw materials being used for the production of anti-aging and anti-wrinkle products. Local players are developing products with organic ingredients to meet the unmet demands of consumers.

For More Insights https://www.biospace.com/article/technological-developments-coupled-with-improved-healthcare-infrastructure-are-key-in-pushing-growth-of-global-atrial-fibrillation-market-finds-fact-mr/

Find More Valuable Insights on Anti-aging and Anti-wrinkle Products Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global anti-aging and anti-wrinkle products market, presenting historical demand data (2017-2019), and forecast statistics for the period of 2020-2027. The study divulges compelling insights on the anti-aging and anti-wrinkle products market on the basis of product (serum, creams, gels, and others), gender (male and female), ingredient (retinoid, hyaluronic acids, alpha-hydroxy acids, and others), treatment (body care treatment and facial care treatment), and distribution channel (pharmacies, stores, and online stores), across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com